New imaging technique accurately detects aggressive kidney cancer
WEB1 day ago · The new imaging method accurately identified the presence of cancer in most cases while minimizing false positives, demonstrating a high performance with 85.5% sensitivity and 87.0% specificity ...
First Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for ...
WEB1 day ago · Professor Brian Shuch, MD, Director of the Kidney Cancer Program and the Alvin & Carrie Meinhardt Endowed Chair in Kidney Cancer Research at UCLA Institute of Urologic Oncology, and Principal ...
Advances in treating kidney cancer
WEBMay 30, 2024 · News, information and stories from Mayo Clinic’s cancer experts and patients ... Most kidney cancer is discovered at an early stage when the cancer is small and confined to the kidney. "Many patients are diagnosed coincidentally by imaging of the abdomen with a small renal mass, and they have a lot of options," says Dr. Potretzke. ...
Study reveals potential new way to stop a common kidney cancer
WEBApr 22, 2024 · Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer, diagnosed in about 76,000 people in the United States each year. If caught early, treatments such as immune checkpoint blockade (ICB) therapy, which bolsters the body’s anti-tumor immune response, can slow cancerous growth.
The Latest Kidney Cancer Treatment Advances: What to Know
WEBNov 1, 2022 · Kidney cancers are among the top 10 most common cancers in both men and women: about 79,000 new cases will be diagnosed in 2022, according to the American Cancer Society. When the cancer is first ...
FDA Approves New Treatment for Advanced Kidney Cancer
WEBDec 18, 2023 · The Food and Drug Administration last week approved Welireg (belzutifan) for patients with advanced kidney cancer who previously used other types of treatment. The December 14 decision marks the first approval of a new class of therapy for advanced renal cell carcinoma (RCC), the most common type of kidney cancer, in nearly a decade.. Welirig is a hypoxia-inducible factor 2 alpha (HIF-2α ...
Subcutaneous Versus IV Nivolumab for Kidney Cancer - NCI
WEBMar 13, 2024 · Nivolumab is an immune checkpoint inhibitor, a type of immunotherapy that helps immune cells attack cancer. It is used to treat more than 10 types of cancer. “Currently, many first-line therapies for metastatic kidney cancer involve an intravenous infusion of a checkpoint inhibitor, which requires trips to an infusion center,” Dr. Ball ...
Adjuvant Keytruda Improves Kidney Cancer Survival - NCI
WEBMay 21, 2024 · Until now, only a single adjuvant therapy for kidney cancer has been available: the targeted therapy sunitinib (Sutent), which was approved by FDA for this use in 2017.. That approval was based on one clinical trial in which adjuvant sunitinib improved disease-free survival.But the improvement came with severe side effects, and there’s no evidence that the treatment helps people live longer ...
FDA approves kidney cancer therapy after Dana-Farber-led …
WEBDec 15, 2023 · "This approval is exciting news for our patients as it gives us a new option for refractory patients with kidney cancer," said Choueiri. "Belzutifan is an oral drug with a novel mechanism of action that reduced risk of disease progression or death and had favorable quality of life in this patient population, when compared to everolimus."
New imaging technique accurately detects aggressive kidney cancer
WEBSep 25, 2024 · Kidney cancers, known as renal cell carcinomas, make up 90% of solid kidney tumors. Every year more than 81,000 people in the United States are diagnosed with kidney cancer. Among the many types of these cancers, the most common and deadly is clear-cell renal cell carcinoma, which accounts for 75% of cases and 90% of kidney cancer deaths.